Recombinant Isfahan Virus Vectored Tri-Valent Vaccine to Protect against Western, Eastern, and Venezuelan Equine Encephalitis Virus

Project: Other project

Project Details

StatusFinished
Effective start/end date7/17/15 → 11/30/17

Funding

  • Profectus BioSciences Incorporated: $876,822.01